171 related articles for article (PubMed ID: 4808028)
1. Effect of whole and lysed sensitized lymphocytes on murine tumor growth and host survival.
Greco RS; Schmidt DR; Storer EH
Surg Forum; 1973; 24():109-11. PubMed ID: 4808028
[No Abstract] [Full Text] [Related]
2. [Problems of the immunotherapy of malignant neoplasma].
Trapeznikov NN; Iavorskiĭ VV
Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
[No Abstract] [Full Text] [Related]
3. Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.
Fefer A
Isr J Med Sci; 1973 Mar; 9(3):350-65. PubMed ID: 4145461
[No Abstract] [Full Text] [Related]
4. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
5. "Immune" RNA--a new model for the immunotherapy of cancer.
Pilch YH
Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
[No Abstract] [Full Text] [Related]
6. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
7. Immune stimulation-inhibition of experimental cancer metastasis.
Fidler IJ
Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
[No Abstract] [Full Text] [Related]
8. Proceedings: Adoptive and passive immunotherapy.
Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR
Proc Natl Cancer Conf; 1972; 7():85-9. PubMed ID: 4764946
[No Abstract] [Full Text] [Related]
9. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
10. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
Southam CM
J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552
[No Abstract] [Full Text] [Related]
11. [Pros and cons of the use of immunotherapeutic procedures with special reference to adoptive immunotherapy in proliferative diseases].
Schneiberg K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(3):337-57. PubMed ID: 6159273
[TBL] [Abstract][Full Text] [Related]
12. Immunity to malignant disease in man.
Fairley GH
Sci Basis Med Annu Rev; 1971; ():17-38. PubMed ID: 4933915
[No Abstract] [Full Text] [Related]
13. [Immunotherapy of malignant tumors].
Adolphs HD
Med Klin; 1975 Feb; 70(7):255-66. PubMed ID: 1091835
[No Abstract] [Full Text] [Related]
14. [Immunotherapy of neoplasms].
Trepel F
Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
[No Abstract] [Full Text] [Related]
15. A new horizon in cancer therapy: Immunotherapy. II.
Thompson RB
J Miss State Med Assoc; 1972 Jan; 13(1):10-3. PubMed ID: 4550110
[No Abstract] [Full Text] [Related]
16. Effect of hypophysectomy on an experimental testicular tumor.
Prudencio RF; Clark SS; Das Gupta TK
Surg Forum; 1973; 24():547-8. PubMed ID: 4806092
[No Abstract] [Full Text] [Related]
17. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
18. Immunotherapy: new hope for the cancer patient.
Costanzi JJ; Goldstein AL
Am Fam Physician; 1973 Nov; 8(5):150-4. PubMed ID: 4542856
[No Abstract] [Full Text] [Related]
19. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
Basombrío MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
20. [Cancer and BCG].
Rumi LS
Acta Physiol Lat Am; 1981; 31(1):25-34. PubMed ID: 7187581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
